Getty Images explores merger with Shutterstock, Bloomberg News reports-March 2024-www.financetom.com

Getty Images explores merger with Shutterstock, Bloomberg News reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Getty Images explores merger with Shutterstock, Bloomberg News reports

Jan 3, 2025 11:26 AM

Jan 3 (Reuters) - Getty Images Holdings ( GETY ) is exploring a merger with its rival

Shutterstock ( SSTK ), Bloomberg News reported on Friday, citing people familiar with the

matter.

Previous page： --Trane Technologies Keeps Quarterly Dividend at $0.94 a Share; Payable June 30 to Holders of Record as of June 6 Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Trane Technologies Keeps Quarterly Dividend at $0.94 a Share; Payable June 30 to Holders of Record as of June 6

Apr 3, 2025

09:59 AM EDT, 04/03/2025 (MT Newswires) -- Price: 334.39, Change: -13.55, Percent Change: -3.89 ...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Amneal Pharmaceuticals' Crexont Added to Three Insurance Coverage Accounts

Apr 3, 2025

10:02 AM EDT, 04/03/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Thursday that the Veterans Administration, UnitedHealthcare (UNH), and CVS Health ( CVS ) have added Parkinson's disease treatment Crexont to their national prescription drug formularies. The company said the additional coverage increases the total US insurance coverage of Crexont to more than 50% of covered patients from...

Akebia Therapeutics Says EMA Panel Recommends Approval of Xoanacyl for Chronic Kidney Disease Treatment

Apr 3, 2025

10:01 AM EDT, 04/03/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Xoanacyl for treating elevated serum phosphorus and iron deficiency in adults with chronic kidney disease. The company said Averoa, a biopharmaceutical company specializing in renal treatments, licensed the rights from Akebia...